Publications

In the listing below you can click on “PMID” for abstract and on “Full text” for complete text of article.

Complete List of Published Work in MyBibliography: https://www.ncbi.nlm.nih.gov/myncbi/annlia.hill.1/bibliography/public/

 Peer-Reviewed Papers

1980s

  1. Hill AP. Quantitative linkage: a statistical procedure for its detection and estimation. Ann Hum Genet Lond 38:439-449, 1975. PMID: 1190735
  2. Wilkinson E, Clopton C, Gordonson J, Green R, Hill A, Pike MC. Mammographic parenchymal pattern and the risk of breast cancer. JNCI 59:1397-1400, 1977. PMID: 909098
  3. DiSaia PJ, Morrow CP, Hill A, Mittelstaedt L. Immune competence and survival in patients with advanced cervical cancer: peripheral lymphocyte counts. Int J Radiation Oncology Biol Phys 4:449-451, 1978. PMID: 689945
  4. Hill AP, Pike MC, Smith PG, Ory HW. Stratified analysis of case-control studies with the factor under study taking multiple values. J Chronic Dis 31:547-555, 1978. PMID: 711847
  5. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr, The Cooperative Liver Tumor Study Group. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 242:644-648, 1979. PMID: 221698
  6. Levine AM, Overturf GD, Field RF, Holdorf D, Paganini-Hill A, Feinstein DI. Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease. Blood 54:1171-1175, 1979. PMID:40635 Full text
  7. Pike MC, Hill AP, Smith PG. Bias and efficiency in logistic analyses of stratified case-control studies. Int J Epidemiology 9:89-95, 1980. PMID: 7419334
  8. Ross RK, Paganini-Hill A, Gerkins VR, Mack TM, Pfeffer R, Arthur M, Henderson BE. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 243:1635-1639, 1980. PMID: 7359751
  9. Preston-Martin S, Paganini-Hill A, Henderson BE, Pike MC, Wood C. Case-control study of intracranial meningiomas in women in Los Angeles County, California. JNCI 65:67-73, 1980. PMID: 6930521
  10. Paganini-Hill A, Glazer E, Henderson BE, Ross RK. Cause-specific mortality among newspaper web pressmen. J Occup Med 22:542-544, 1980. PMID: 7400867
  11. Ross RK, Deapen DM, Casagrande JT, Paganini-Hill A, Henderson BE. A cohort study of mortality from cancer of the prostate in Catholic priests. Br J Cancer 43:233-235, 1981. PMID: 7470386 Full text
  12. Mack TM and Paganini-Hill A. Epidemiology of pancreas cancer in Los Angeles. Cancer 47:1474-1483, 1981. PMID: 7272907
  13. Ross RK, Paganini-Hill A, Mack TM, Arthur M, Henderson BE. Menopausal oestrogen therapy and protection from death from ischaemic heart disease death. Lancet i:858-860, 1981. PMID: 6112292
  14. Paganini-Hill A, Martin AO, Spence MA. The S-leut anthropometric traits: genetic analysis. Am J Phys Anthro 55:55-67, 1981. PMID: 7258336
  15. Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. Menopausal estrogen therapy and hip fractures. Ann Intern Med 95:28-31, 1981. PMID: 7247123
  16. Smith PG, Pike MC, Hill AP, Breslow NE, Day NE. Algorithm AS162 Multivariate conditional logistic analysis of stratum-matched case-control studies. Applied Statistics 30:190-197, 1981.
  17. Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 54:115-120, 1982. PMID: 7198650
  18. Paganini-Hill A and Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 116:114-122, 1982. PMID: 7102647
  19. Gould-Martin K, Paganini-Hill A, Casagrande C, Mack T, Ross RK. Behavioral and biological determinants of surgical stage of breast cancer. Preventive Medicine 11:429-440, 1982. PMID: 7122433
  20. Ross R, Dworsky R, Nichols P, Paganini-Hill A, Wright W, Kos M, Lakes R, Henderson B. Asbestos exposure and lymphomas of the gastrointestinal tract and oral cavity. Lancet ii:1118-1120, 1982. PMID: 6128448
  21. Levine AM, Foeman SJ, Meyer PR, Koehler SC, Liebman H, Paganini-Hill A, Pockros A, Lukes RJ, Feinstein DI. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood 61:92-98, 1983. PMID: 6600214 Full text
  22. Weinberg DM, Ross RK, Mack TM, Paganini-Hill A, Henderson BE. Bladder cancer etiology. A different prospective. Cancer 51:675-680, 1983. PMID: 6821840
  23. Ross RK, Garbeff P, Paganini-Hill A, Henderson BE. Effect of in-utero exposure to diethylstilbestrol on age at onset of puberty and postpubertal hormone levels in boys. Canad Med Assoc J 128:1197-1198, 1983. PMID: 6839243 Full text
  24. Ross R, Dworsky R, Paganini-Hill A, Boone J, Nichols P, Mack T. The occurrence of multiple lymphorecticular and hematological malignancies in the same households. Br J Cancer 47:853-856, 1983. PMID: 6860551 Full text
  25. Gray GE, Paganini-Hill A, Ross RK. Dietary intake and nutrient supplement use in a Southern California retirement community. Am J Clin Nutr 38:122-128, 1983. PMID: 6858946 Full text
  26. Dworsky R, Paganini-Hill A, Arthur M, Parker J. Immune responses of healthy humans 83-104 years of age. JNCI 71:265-268, 1983. PMID: 6576185
  27. Levine AM, Pavlova Z, Pockros AW, Parker JW, Teitelbaum AH, Paganini-Hill A, Powars DR, Lukes RJ, Feinstein DI. Small noncleaved follicular center cell (FCC) lymphoma: Burkitt and non-Burkitt variants in the United States. I. Clinical features. Cancer 52:1073-1079, 1983. PMID: 6349778
  28. Paganini-Hill A, Krailo MD, Pike MC. Age at natural menopause and breast cancer risk: the effect of errors in recall. Am J Epidemiol 119:81-85, 1984. PMID: 6691338
  29. Gray GE, Paganini-Hill A, Ross RK, Henderson BE. Assessment of three brief methods of estimation of vitamin A and C intakes for a prospective study of cancer: comparison with dietary history. Am J Epidemiol 119:581-590, 1984. PMID: 6711547
  30. Blanco D, Ross RK, Paganini-Hill A, Henderson BE. Cholecystectomy and colonic cancer. Dis Colon Rectum 27:290-292, 1984. PMID: 6714043
  31. Ross RK, Paganini-Hill A, Krailo MD, Gerkins VR, Henderson BE, Pike MC. Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women. Cancer Research 44:3106-3108, 1984. PMID: 6722826 Full text
  32. Levine AM, Goldstein M, Meyer PR, Forman SJ, Parker JW, Paganini-Hill A, Lukes RJ, Feinstein DI. Heterogeneity of response and survival in diffuse histiocytic lymphoma after BACOP therapy (bleomycin, doxorubicin, cyclophosphamide, vincristine, prednisone). Hematological Oncology 3:87-98, 1985. PMID: 2410348
  33. Ross R, Dworsky R, Paganini-Hill A, Levine A, Mack T. Non-Hodgkin’s lymphoma in never married men in Los Angeles. Br J Cancer 52:785-787, 1985. PMID: 4063152 Full text
  34. Stewart ML, Felman IE, Nichols PW, Paganini-Hill A, Lukes RJ, Levine AM. Large noncleaved follicular center cell lymphoma. Clinical features in 53 patients. Cancer 57:288-297, 1986. PMID: 3510701
  35. Gray GE, Paganini-Hill A, Ross RK, Henderson BE. Vitamin supplement use in a Southern California retirement community. J Am Dietetic Assoc 86:800-802, 1986. PMID: 3711563
  36. Paganini-Hill A, Ross RK, Henderson BE. Prevalence of chronic disease and health practices in a retirement community. J Chron Dis 39:699-707, 1986. PMID: 3734024
  37. Ross RK, Shimizu H, Paganini-Hill A, Honda G, Henderson BE. Case-control studies of prostate cancer in blacks and whites in southern California. JNCI 78:869-874, 1987. PMID: 3471995
  38. Goldstein AM, Haile RWC, Marazita ML, Paganini-Hill A. A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer. I. Segregation analysis. JNCI 78:911-918, 1987. PMID: 3472000
  39. Wu AH, Paganini-Hill A, Ross RK, Henderson BE. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 55:687-694, 1987. PMID: 3620314 Full text
  40. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Vitamin A, β-carotene, and the risk of cancer: a prospective study. JNCI 79:443-448, 1987. PMID: 3476787
  41. Chao A, Paganini-Hill A, Ross RK, Henderson BE. Use of preventive care by the elderly. Preventive Medicine 16:710-722, 1987. PMID: 3684980
  42. Goldstein AM, Haile RWC, Hodge SE, Paganini-Hill A, Spence MA. Possible heterogeneity in the segregation pattern of breast cancer in families with bilateral breast cancer. Genetic Epidemiology 5:121-133, 1988. PMID: 3402724
  43. Ross RK, Paganini-Hill A, Roy S, Chao A, Henderson BE. Past and present preferred prescribing practices of hormone replacement therapy among Los Angeles gynecologists: possible implications for public health. Am J Public Health 78:516-519, 1988. PMID: 3354733 Full text
  44. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. Brit Med J 297:519-522, 1988. PMID: 3139181 Full text
  45. Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol 159:312-317, 1988. PMID: 3251473
  46. Ross RK, Paganini-Hill A, Landolph J, Gerkins V, Henderson BE. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Research 49:1045-1048, 1989. PMID: 2912549 Full text
  47. Paganini-Hill A, Ross RK, Henderson BE. Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study. Br J Cancer 59:445-447, 1989. PMID: 2930713 Full text
  48. Dworsky R, Paganini-Hill A, Ducey B, Hechinger M, Parker JW. Lymphocyte immunophenotyping in an elderly population: age, sex and medication effects — a flow cytometry study. Mechanisms of Ageing and Development 48:255-266, 1989. PMID: 2786599
  49. Goldstein AM, Haile RW, Spence MA, Sparkes RS, Paganini-Hill A. A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer II. Linkage analysis. Clinical Genetics 36:100-106, 1989. PMID: 2766568
  50. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Aspirin use and chronic diseases: a cohort study of the elderly. Brit Med J 299:1247-1250, 1989. PMID: 2513898 Full text

     1990s

  51. Haile RW, Goldstein AM, Weeks DE, Sparks RS, Paganini-Hill A. Genetic epidemiology of bilateral breast cancer: a linkage analysis using the affected-pedigree-member method. Genetic Epidemiol 7:47-55, 1990. PMID: 2328913
  52. Ross RK, Bernstein L, Trent L, Henderson BE, Paganini-Hill A. A prospective study of risk factors for traumatic deaths in a retirement community. Preventive Med 19:323-334, 1990. PMID: 2377594
  53. Ameriso SF, Paganini-Hill A, Meiselman HJ, Fisher M. Correlates of middle cerebral artery blood velocity in the elderly. Stroke 21:1579-1583, 1990. PMID: 2237952 Full text
  54. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151:75-78, 1991. PMID: 1985611
  55. Paganini-Hill A, Chao A, Ross RK, Henderson BE. Exercise and other factors in the prevention of hip fracture: the Leisure World Study. Epidemiology 2:16-25, 1991. PMID: 2021661
  56. Shibata A, Paganini-Hill A, Ross RK, Yu MC, Henderson BE. Dietary β-carotene, cigarette smoking, and lung cancer in men. Cancer Causes and Control 3:207-214, 1992. PMID: 1610967
  57. Ursin G, Aragaki CC, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Oral contraceptives and premenopausal bilateral breast cancer: a case-control study. Epidemiology 3:414-419, 1992. PMID: 1391133
  58. Shibata A, Paganini-Hill A, Ross RK, Henderson BE. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 66:673-679, 1992. PMID: 1419605 Full text
  59. Fisher M, Brant-Zawadzki M, Ameriso S, Quismorio F, Wong V, Bernard J, Zee C-S, Paganini-Hill A. Subcortical magnetic resonance imaging changes in a healthy elderly population: stroke risk factors, ultrasound, and hemostasis findings. J Neuroimag 3:28-32, 1993.
  60. Haile RW, Cortessis VK, Millikan R, Ingles S, Aragaki CC, Richardson L, Thompson WD, Paganini-Hill A, Sparkes RS. A linkage analysis of D17S74 (CMM86) in thirty-five families with premenopausal bilateral breast cancer. Cancer Research 53:212-214, 1993. PMID: 8417809 Full text
  61. Paganini-Hill A, Hsu G, Chao A, Ross RK. Comparison of early and late respondents to a postal health survey questionnaire. Epidemiology 4:375-379, 1993. PMID: 8347749
  62. Macko RF, Ameriso SF, Akmal M, Paganini-Hill A, Mohler JG, Massry SG, Meiselman HJ, Fisher M. Arterial oxygen content and age are determinants of middle cerebral artery blood flow velocity. Stroke 24:1025-1028, 1993. PMID: 8322377 Full text
  63. Paganini-Hill A, Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol 138:101-106, 1993. PMID: 8342528
  64. Cortessis V, Ingles S, Millikan R, Diep A, Gatti RA, Richardson L, Thompson WD, Paganini-Hill A, Sparkes RS, Haile RW. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal breast cancer. Cancer Research 53:5083-5086, 1993. PMID: 8221639 Full text
  65. Shibata A, Mack TM, Paganini-Hill A, Ross RK, Henderson BE. A prospective study of pancreatic cancer in the elderly. Intl J Cancer 58:46-49, 1994. PMID: 8014014
  66. Paganini-Hill A, Hsu G. Smoking and mortality among residents of a California retirement community. Am J Public Health 84:992-995, 1994. PMID: 8203698 Full text
  67. Ursin G, Paganini-Hill A, Siemiatycki J, Thompson WD, Haile RW. Early adult body weight, body mass index and premenopausal bilateral breast cancer: data from a case-control study. Breast Cancer Research and Treatment 33:75-82, 1994. PMID: 7749135
  68. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 140:256-261, 1994. PMID: 8030628
  69. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women. Comparisons between Alzheimer’s disease cases and nondemented control subjects. Archives of Neurology 51:896-900, 1994. PMID: 8080389
  70. Longnecker MP, Paganini-Hill A, Ross RK. Lifetime alcohol consumption and breast cancer risk among postmenopausal women in Los Angeles. Cancer Epidemiol Biomarkers Prevention 4:721-725, 1995. PMID: 8672988 Full text
  71. Paganini-Hill A. The benefits of estrogen replacement therapy on oral health: the Leisure World Cohort. Arch Intern Med 155:2325-2329, 1995. PMID: 7487257
  72. Haile RW, Witte JS, Ursin G, Siemiatycki J, Bertolli J, Thompson WD, Paganini-Hill A. A case-control study of reproductive variables, alcohol and smoking in premenopausal bilateral breast cancer. Breast Cancer Res Treat 37:49-56, 1996. PMID: 8750527
  73. Paganini-Hill A, Dworsky R, Krauss RM. Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women. Am J Obstet Gynecol 174:897-902, 1996. PMID: 8633665
  74. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713-1727, 1996. PMID: 8656904
  75. Fisher M, Fernández JA, Ameriso SF, Xie D, Gruber A, Paganini-Hill A, Griffin JH. Activated protein C resistance in ischemic stroke not due to factor V Arginine506 →Glutamine mutation. Stroke 27:1163-1166, 1996. PMID: 8685921 Full text
  76. Paganini-Hill A, Henderson VW. The effects of hormone replacement therapy, lipoprotein cholesterol levels and other factors on a clock drawing task in elderly women. J Am Geriatric Soc 44:818-822, 1996. PMID: 8675931
  77. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: further results. Contraception 54(3) Suppl:1S-106S, 1996. PMID: 8899264
  78. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer’s disease. Arch Intern Med 156:2213-2217, 1996. PMID: 8885820
  79. Longnecker MP, Bernstein L, Paganini-Hill A, Enger SM, Ross RK. Risk factors for in situ breast cancer. Cancer Epidemiol Biomarkers Prevention 5:961-965, 1996. PMID: 8959317 Full text
  80. Witte JS, Ursin G, Siemiatycki J, Thompson WD, Paganini-Hill A, Haile RW. Diet and premenopausal bilateral breast cancer: a case-control study. Breast Cancer Research Treatment 42:243-251, 1997. PMID: 9065608
  81. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 350:1047-1059, 1997. PMID: 10213546
  82. Enger SM, Ross RK, Paganini-Hill A, Bernstein L. Breastfeeding experience and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prevention 7:365-369, 1998. PMID: 9610784 Full text
  83. Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Urinary 2-hydroxyestrone/16α-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. JNCI 91:1067-1072, 1999. PMID: 10379970 Full text
  84. Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L. Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 79:1308-1314, 1999. PMID: 10098777 Full text
  85. Paganini-Hill A. Estrogen replacement therapy and colorectal cancer risk in elderly women. Dis Colon Rectum 42:1300-1305, 1999. PMID: 10528768
  86. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Lifetime exercise activity and breast cancer risk among post-menopausal women. Br J Cancer 80:1852-1858, 1999. PMID: 10468309 Full text

     2000s

  87. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klien RA, Hake AM, Farlow MR. Estrogen for Alzheimer’s disease in women. Randomized, double-blind, placebo-controlled trial. Neurology 54:295-301, 2000. PMID: 10668686
  88. Paganini-Hill A, Clark LJ. Eye problems in breast cancer patients treated with tamoxifen. Breast Cancer Research Treatment 60:167-172, 2000. PMID: 10845279
  89. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst 92:328-332, 2000. PMID: 10675382 Full text
  90. Paganini-Hill A, Clark LJ. Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Research Treatment 64:165-176, 2000. PMID: 11194452
  91. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prevention 9:681-687, 2000. PMID: 10919738 Full text
  92. Paganini-Hill A. Risk factors for Parkinson’s disease: the Leisure World Cohort Study. Neuroepidemiol 20:118-124, 2001. PMID: 11359079
  93. Paganini-Hill A, Perez Barreto M. Stroke risk in older men and women: aspirin, estrogen, exercise, vitamins, and other factors. J Gender Specific Med 4(2):18-28, 2001. PMID: 11480094
  94. Paganini-Hill A, Clark LJ, Henderson VW, Birge SJ. Clock drawing: analysis in a retirement community. J Am Geriatrics Soc 49:941-947, 2001. PMID: 11527486
  95. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58209 women with breast cancer and 101986 women without the disease. Lancet 358:1389-1399, 2001. PMID: 11705483
  96. Ursin G, Tseng CC, Paganini-Hill A, Enger S, Wan PC, Formenti S, Pike MC, Ross RK. Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clinical Oncology 20:699-706, 2002. PMID: 1182145
  97. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360:187-195, 2002. PMID: 12133652
  98. Heeb MJ, Paganini-Hill A, Griffin JH, Fisher M. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells, Molecules, and Diseases 29:139-144, 2002. PMID: 12490280
  99. Collaborative Group on Hormonal Factors in Breast Cancer. Alcohol, tobacco and breast cancer: collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95067 women without the disease. Br J Cancer 87:1234-1245, 2002. PMID: 12439712 Full text
  100. Paganini-Hill A, Lozano E, Fischberg G, Perez Barreto M, Rajamani K, Ameriso SF, Heseltine PNR, Fisher M. Infection and risk of ischemic stroke. Differences among stroke subtypes. Stroke 34:452-457, 2003. PMID: 12574559 Full text
  101. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L. Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 106:96-102, 2003. PMID: 12794763
  102. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abortion: collaborative reanalysis of individual data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 363:1007-1016, 2004. PMID: 15051280
  103. Fisher M, Paganini-Hill A, Martin A, Cosgrove M, Toole JF, Barnett HJM, Norris J. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke 36:253-257, 2005. PMID: 15653581 Full text
  104. White SC, Atchison KA, Gornbein JA, Nattiv A, Paganini-Hill A, Service SK, Yoon DC. Change in mandibular trabecular pattern and hip fracture rate in elderly women. Dentomaxillofacial Radiology 34:168-174, 2005. PMID: 15897288
  105. Paganini-Hill A, Atchison KA, Gornbein JA, Nattiv A, Service SK, White SC. Menstrual and reproductive factors and fracture risk: the Leisure World Cohort Study. J Women’s Health 14:808-819, 2005. PMID: 16313208
  106. Paganini-Hill A, Corrada M, Kawas CH. Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause 13:12-18, 2006. PMID: 16607094 Full text
  107. Corrada M, Kawas CH, Mozaffar F, Paganini-Hill A. Association of body mass index and weight change with all-cause mortality in the elderly. Am J Epidemiol 163:938-949, 2006. PMID: 16641311 Full text
  108. White SC, Atchison KA, Gornbein JA, Nattiv A, Paganini-Hill A, Service SK. Risk factors for fractures in older men and women: the Leisure World Cohort Study. Gender Medicine 3:110-123, 2006. PMID: 16860270
  109. Paganini-Hill A, Clark LJ. Preliminary assessment of cognitive function in older adults by clock drawing, box copying and narrative writing. Dement Geriatr Cogn Disord 23:74-81, 2007. PMID: 17114883
  110. Paganini-Hill A, Clark LJ. Comparison of patient recall of hormone therapy with physician records. Menopause 14:1-5, 2007. PMID: 17108846
  111. Paganini-Hill A, Kawas CH, Corrada M. Type of alcohol consumed, changes in intake over time and mortality: the Leisure World Cohort Study. Age and Ageing 36:203-209, 2007. PMID: 17350977 Full text
  112. Paganini-Hill A, Kawas CH, Corrada M. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Preventive Medicine 44:305-310, 2007. PMID: 17275898 Full text
  113. Whittle C, Corrada M, Dick M, Ziegler R, Kahle-Wrobleski K, Paganini-Hill A, Kawas C. Neuropsychological data in nondemented oldest old: The 90+ Study. Journal of Clinical & Experimental Neuropsychology 29:290-299, 2007. PMID: 17454349 Full text
  114. Corrada MM, Brookmeyer R, Berlau D, Paganini-Hill A, Kawas CH. Prevalence of dementia after age 90: Results from The 90+ Study. Neurology 71:337-343, 2008. PMID: 18596243
  115. Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson BL, Paganini-Hill A, Geiger MJ, Dowsett SA, Amewou-Atisso M, Kornitzer M. Effect of raloxifene on stroke and venous thromboembolism: A randomized controlled trial in postmenopausal women with or at increased risk of coronary heart disease. Stroke 40:147-155, 2009. PMID: 18948611 Full text

     2010s

  116. Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest old: the 90+ Study. Annals of Neurology 67:114-121, 2010. PMID: 20186856 Full text
  117. Paganini-Hill A. Lifestyle practices and cardiovascular disease mortality in the elderly: the Leisure World Cohort Study. Cardiology Research and Practice Article ID 983764, 7 pages, 2011. PMID: 21274456 Full text
  118. Paganini-Hill A, Kawas CH, Corrada MM. Activities and mortality in the elderly: the Leisure World Cohort Study. J Gerontology Series A: Biomedical Sciences and Medical Sciences 66:559-567, 2011. PMID: 21350247 Full text
  119. Paganini-Hill A, Clark L. Longitudinal assessment of cognitive function by clock drawing in older adults. Dementia and Geriatric Cognitive Disorders EXTRA.1:75-83, 2011. PMID: 22163235 Full text
  120. Paganini-Hill A, White SC, Atchison KA. Dental health behaviors, dentition and mortality in the elderly: the Leisure World Cohort Study. J Aging Research 2011:156061622753, 2011. PMID: 21748004 Full text
  121. Liu S, Marder, VJ, Levy DE, Wang S-J, Yang F, Paganini-Hill A. Fisher MJ. Ancrod and fibrin formation: perspectives on mechanisms of action. Stroke 42:3277-80, 2011. PMID: 21868728 Full text
  122. Yang F, Liu S, Wang S-J, Yu C. Paganini-Hill A. Fisher MJ. Tissue plasminogen activator expression and barrier properties of human brain microvascular endothelial cells. Cellular Physiology & Biochemistry 28:631-638, 2011. PMID: 22178875
  123. Paganini-Hill A. Hypertension and dementia in the elderly: the Leisure World Cohort Study. Intl J Hypertension Volume 2012, Article ID 205350, 5 pages, 2012. PMID: 22229084 Full text
  124. Yang F, Liu S, Yu C, Wang S-J, Paganini-Hill A, Fisher MJ. PDE4 Regulates Tissue Plasminogen Activator Expression of Human Brain Microvascular Endothelial Cells. Thrombosis Research 129:750-753, 2012. PMID: 22245243
  125. Paganini-Hill A, White SC, Atchison KA. Dentition, dental health habits, and dementia: the Leisure World Cohort Study. J Am Geriatric Soc 60:1556-1563, 2012. PMID: 22860988
  126. Liu S, Yu c, Yang F, Paganini-Hill A, Fisher MJ. Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties. J Neurological Sciences 320:45-51, 2012. PMID: 22819056
  127. Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause and breast cancer risk: individual participant meta-analysis, including 118,964 women with breast cancer from 117 epidemiological studies. Lancet Oncology 13:1141-1151, 2012. PMID: 23084519
  128. Corrada MM, Paganini-Hill A, Berlau DJ, Kawas CH. APOE genotype, dementia and mortality in the oldest-old: The 90+ Study. Alzheimer’s & Dementia 9:12-18, 2013. PMID: 23123227
  129. Paganini-Hill A. Aging in place in a retirement community: 90+ year-olds. J Housing Elderly 27:1-2, 191-205, 2013.  PMID: 25288828 Full text
  130. Paganini-Hill A, Ducey B, Hawk M. Responders versus nonresponders in a dementia study of the oldest-old. Am J Epidemiol 177:1452-1458, 2013. PMID: 23568592 Full text
  131. Liu S, Grigoryan MM, Vasilevko V, Sumbria RK, Paganini-Hill A, Cribbs D, Fisher MJ. Comparative analysis of H&E and Prussian blue staining in a mouse model of cerebral microbleeds. J Histochem Cytochem 1-7, 2014. DOI: 10.1369/0022155414546692. PMID: 25063000 Full text
  132. Yang F, Sumbria SK, Xue D, Yu C, Liu S, Paganini-Hill A, Fisher MJ. Effects of PDE4 pathway inhibition in rat experimental stroke. J Pharm Pharm Sci 17:362-370, 2014.  PMID: 25224348 Full Text
  133. Paganini-Hill A, Kawas CH, Corrada MM. Antioxidant vitamin intake and mortality: the Leisure World Cohort Study. Am J Epidemiol, 181(2):120-6, 2015. doi: 10.1093/aje/kwu294. Epub 2014 Dec 29.  PMID: 25550360
  134. Wong JM, Lombardo DM, Barseghian A, Dhoot J, Hundal HS, Salcedo J, Paganini-Hill A, Wong ND, Fisher M.  Left atrial septal pouch in cryptogenic stroke. Front Neurol. 2015 Mar 24;6:57. doi: 10.3389/fneur.2015.00057. eCollection 2015.  PMID: 25852636 Full Text
  135. Pabalan N, Singian E, Jarjanazi H, Paganini-Hill A. Association of male circumcision with risk of prostate cancer: a meta-analysis. Prostate Cancer and Prostatic Disease 2015 Jul 28, 1-6.
  136. Fisher M, Moores L, Alsharif MN, Paganini-Hill A. Definition and implications of preventable stroke. JAMA Neurol. doi:10.1001/jamaneurol.2015.3587
  137. Brookmeyer R, Kawas CH, Abdallah N, Paganini-Hill A, Kim RC, Corrada MM. Impact of interventions to reduce Alzheimer’s disease pathology on the prevalence of dementia in the oldest-old. Alzheimer’s & Dementia. 12:225-32, 2016.
  138. Paganini-Hill A, Kawas CH, Corrada MM. Lifestyle factors and dementia in the oldest-old: The 90+ Study. Alzheimer Dis Assoc Disord. 30(1):21-6, 2016. PMID: 25710250
  139. Sumbria RK, Grigoryan MM, Viailevko V, Krasieva TB, Scadeng M, Dvomikova AK, Paganini-Hill A, Kim R, Cribbs DH, Fisher MJ. A murine model of inflammation-induced cerebral microbleeds. J Neuroinflammation 13:218, 1-12, 2016.
  140. Lee JS, Ko KH, Oh J-H, Park JH, Lee HK, Floriolli D, Paganini-Hill A, Fisher M. Cerebral microbleeds, hypertension, and intracerebral hemorrhage in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Front Neurol. 2017 May 8:203. doi: 10.3389/fneur.2017.00203
  141. Paganini-Hill A, Greenia DE, Perry S, Sajjadi SH, Kawas CH, Corrada. Lower likelihood of falling at age 90+ is associated with daily exercise a quarter of a century earlier: The 90+ Study. Age and Ageing 2017; 46: 951–957. doi: 10.1093/ageing/afx039
  142. Yang WJ, Fisher M, Zheng L, Niu CB, Paganini-Hill A, Zhao HL, Xu Y, Wong KS, Ng HK, Chen XY. Histological characteristics of intracranial atherosclerosis in a Chinese population: a postmortem study. Front. Neurol. 2017 Sep 8:488.doi: 10.3389/fneur.2017.00488
  143. Corrada MM, Hayden KM, Paganini-Hill A, Bullain SS, DeMoss J, Aguirre C, Brookmeyer R, Kawas CH. Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study. Alzheimer’s & Dementia 13:103-110, 2017. doi.org/10.1016/j.jalz.2016.09.007
  144. Sumbria RK, Vasilevko V, Grigoryan MM, Paganini-Hill A, Kim R, Cribbs DH, Fisher MJ. Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages. Journal of Neuroinflammation 14:114, 2017. doi.1186/s12974-017-0885-7.
  145. Sumbria RK,  Grigoryan MM, Vasilevko V,Paganini-Hill A, Kilday K, Kim RC, Cribbs DH, Fisher MJ. Aging exacerbates development of cerebral microbleeds in a mouse model. Journal of Neuroinflammation 15:69, 2018. doi.org/10.1186/s12974-018-1092-x.
  146. Paganini-Hill A, Corrada MM, Kawas CH. Increased longevity in older users of postmenopausal estrogen therapy: the leisure world cohort study. Menopause. 25:1256-1261, 2018.
  147. Paganini-Hill A, Kawas CH, Corrada MM. Positive mental attitude associated with lower 35-year mortality: the leisure world cohort study. J Aging Res. 2018:2126368, 2018
  148. Cho AH, Wadi L, Chow D, Chang P, Floriolli D, Shah K, Paganini-Hill A, Fisher M. Cerebral microbleeds in a stroke prevention clinic. Diagnostics (Basel). 10, 18, 2019.
  149. Melikyan ZA, Corrada MM, Dick MB, Whittle C, Paganini-Hill A, Kawas CH. Neuropsychological test norms in cognitively intact oldest-old. J Int Neuropsychol Soc. 25:530-545, 2019.
  150. MJ. Effects of dabigatran in mouse models of aging and cerebral amyloid angiopathy. Front Neurol. 10:966, 2019.
  151. Paganini-Hill A, Bryant N, Corrada MM, Greenia DE, Fletcher E, Singh B, et al. Blood pressure circadian variation, cognition and brain imaging in 90+ year-olds. Front Aging Neurosci. 11:54, 2019.
  152. Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet 394:1159-1168, 2019.

     2020s

  153. Lau WL, Fisher M, Greenia D, Floriolli D, Fletcher E, Singh B, Sajjadi AS, Corrada M, Whittle C, Kawas CH, Paganini-Hill A. Cystatin c, cognition, and brain MRI findings in 90+-year-olds. Neurobiol Aging. 93:78-84, 2020.
  154. Lau WL, Nunes ACF, Vasilevko V, Floriolli D, Lertpanit L, Savoj J, Bangash M, Yao Z, Shah K, Naqvi S, Paganini-Hill A, Vaziri N, Cribbs DH, Fisher M. Chronic kidney disease increases cerebral microbleeds in mouse and man. Transl Stroke Res. 11:122-134, 2020
  155. Paganini-Hill A, Corrada MM, Kawas CH. Prior endogenous and exogenous estrogen and incident dementia in the 10th decade of life: The 90+ study. Climacteric. 23:311-315, 2020.
  156. Wadi LC, Grigoryan MM, Kim RC, Fang C, Kim J, Corrada MM, Paganini-Hill A, Fisher MJ. Mechanisms of cerebral microbleeds. J Neuropathol Exp Neurol. 79:1093-1099, 2020.
  157. Fisher M, Phoenix D, Powell S, Mousa M, Rosenberg S, Greenia D, Corrada MM, Kawas C, Paganini-Hill A. Cognition and political ideology in aging. J Am Geriatr Soc. 69:762-766, 2021.
  158. Kapoor R, Wadi L, Becerra B, Eskander M, Razmara A, Lombardo D, Paganini-Hill A, Kim JK, Fisher M. The left atrial septal pouch: A new stroke risk factor? Transl Stroke Res. 12:205-211, 2021.
  159. Suzuki S, Wadi L, Moores L, Yuki I, Kim J, Xu J, Paganini-Hill A, Fisher M. Stroke Preventability in Large Vessel Occlusion Treated With Mechanical Thrombectomy. Front Neurol. 2021;12:608084. doi: 10.3389/fneur.2021.608084. eCollection 2021. PubMed PMID: 33763011; PubMed Central PMCID: PMC7982657.
  160. Sun J, Vyas P, Mann S, Paganini-Hill A, Nunes ACF, Lau WL, Cribbs DH, Fisher MJ, Sumbria RK. Insights Into the Mechanisms of Brain Endothelial Erythrophagocytosis. Front Cell Dev Biol. 2021;9:672009. doi: 10.3389/fcell.2021.672009. eCollection 2021. PubMed PMID: 34409026; PubMed Central PMCID: PMC8365766.
  161. Lau WL, Fisher M, Fletcher E, DeCarli C, Troutt H, Corrada MM, Kawas C, Paganini-Hill A. Kidney Function Is Not Related to Brain Amyloid Burden on PET Imaging in The 90+ Study Cohort. Front Med (Lausanne). 2021;8:671945. doi: 10.3389/fmed.2021.671945. eCollection 2021. PubMed PMID: 34616751; PubMed Central PMCID: PMC8488112.
  162. Tapia D, Floriolli D, Han E, Lee G, Paganini-Hill A, Wang S, Zandihaghighi S, Kimonis V, Fisher M. Prevalence of cerebral small vessel disease in a Fabry disease cohort. Mol Genet Metab Rep. 2021 Dec;29:100815. doi: 10.1016/j.ymgmr.2021.100815. eCollection 2021 Dec. PubMed PMID: 34745889; PubMed Central PMCID: PMC8551215.
  163. Yu HJ, Wadi L, Say I, Paganini-Hill A, Chow D, Jafari AH, Farhan SD, Del Sol SR, Mobayed O, Alvarez A, Hasso A, Li SS, Do H, Berkeley D, Lee YP, Su LM, Rosen C, Fisher M. Magnetic Resonance Imaging Findings in High School Football Players: Brain and Cervical Spine. Neurotrauma Rep. 2022;3(1):129-138. doi: 10.1089/neur.2021.0026. eCollection 2022. PubMed PMID: 35403100; PubMed Central PMCID: PMC8985528.
  164. Sun J, Ou W, Han D, Paganini-Hill A, Fisher MJ, Sumbria RK. Comparative studies between the murine immortalized brain endothelial cell line (bEnd.3) and induced pluripotent stem cell-derived human brain endothelial cells for paracellular transport. PLoS One. 2022;17(5):e0268860. doi: 10.1371/journal.pone.0268860. eCollection 2022. PubMed PMID: 35613139; PubMed Central PMCID: PMC9132315.
  165. Paganini-Hill A, Montine TJ, Bukhari SA, Corrada MM, Kawas CH, Sajjadi SA. LATE and potential estrogen-related risk factors collected 30 years earlier: The 90+ Study. J Neuropathol Exp Neurol. 2023 Jan 20;82(2):120-126. doi: 10.1093/jnen/nlac119. PubMed PMID: 36562637; PubMed Central PMCID: PMC9852944.
  166. Paganini-Hill A, Bukhari S, Montine TJ, Corrada MM, Kawas CH. Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier: The 90+ Study. Alzheimer Dis Assoc Disord. 2023 Jan-Mar 01;37(1):1-6. doi: 10.1097/WAD.0000000000000551. Epub 2023 Feb 23. PubMed PMID: 36821174; PubMed Central PMCID: PMC9976331.
  167. Fang C, Lau WL, Sun J, Chang R, Vallejo A, Lee D, Liu J, Liu H, Hung YH, Zhao Y, Paganini-Hill A, Sumbria RK, Cribbs DH, Fisher M. Chronic kidney disease promotes cerebral microhemorrhage formation. J Neuroinflammation. 2023 Feb 25;20(1):51. doi: 10.1186/s12974-023-02703-2. PubMed PMID: 36841828; PubMed Central PMCID: PMC9960195.
  168. Magaki S, Chen Z, Severance A, Williams CK, Diaz R, Fang C, Khanlou N, Yong WH, Paganini-Hill A, Kalaria RN, Vinters HV, Fisher M. Neuropathology of microbleeds in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Neuropathol Exp Neurol. 2023 Mar 20;82(4):333-344. doi: 10.1093/jnen/nlad004. PubMed PMID: 36715085; PubMed Central PMCID: PMC10025882.
  169. Neuville RS, Biswas R, Ho CC, Bukhari S, Sajjadi SA, Paganini-Hill A, Montine TJ, Corrada MM, Kawas CH. Study of neuropathological changes and dementia in 100 centenarians in The 90+ Study. Alzheimers Dement. 2023 Aug;19(8):3417-3425. doi: 10.1002/alz.12981. Epub 2023 Feb 16. PubMed PMID: 36795955; PubMed Central PMCID: PMC10427735.
  170. Melikyan ZA, Kawas CH, Paganini-Hill A, Jiang L, Mander BA, Corrada MM. Self-reported sleep in relation to risk of dementia a quarter of a century later at age 90+: The 90+ Study. Behav Sleep Med. 2023 Sep 3;21(5):620-632. doi: 10.1080/15402002.2022.2148668. Epub 2022 Nov 23. PubMed PMID: 37540023; PubMed Central PMCID: PMC10403699.

Letters to the Editor

  1. Pike MC, Hill AP, Smith PG. Letter to the Editor. Int J Epidemiol 10:393-394, 1981. PMID: 7327840
  2. Paganini-Hill A and Ross RK. Breast lumps and consultation delays. Lancet i:995, 1981. PMID: 6112402
  3. Paganini-Hill A and Ross RK. Estrogen replacement therapy, hot flushes and breast cancer. Canad Med Assoc J 127:360, 1982. PMID: 7104912 Full text
  4. Paganini-Hill A and Ross RK. Breast cancer and alcohol consumption. Lancet ii:626-627, 1983. PMID: 6136775
  5. Gray GE, Ross RK, Paganini-Hill A, Henderson BE. More on vitamin E. New Engl J Med 309:924, 1983. PMID: 6888488
  6. Pike MC, Ross RK, Henderson BE, Paganini-Hill A. Postmenopausal estrogen use and heart disease. New Engl J Med 315:132-133, 1986.
  7. Paganini-Hill A, Ross RK, Henderson BE. Vitamin A, β-carotene, and the risk of cancer (reply). JNCI 80:76, 1988.
  8. Paganini-Hill A, Wu A, Chao A. RE: “The relations of alcoholic beverage use to colon and rectal cancer” Am J Epidemiol 132:394, 1990. PMID: 2372015
  9. Paganini-Hill A, Ross RK, Henderson BE. Aspirin use and chronic diseases (reply). Br Med J 300:117, 1990.
  10. Paganini-Hill A, Hsu G, Ross RK, Henderson BE. Aspirin use and incidence of large-bowel cancer in a California retirement community. JNCI 83:1182-1183, 1991. PMID: 1886151
  11. Paganini-Hill A, Hsu G, Ducey B, Hawk M. Hip fracture mortality and prospective payment system. Arch Intern Med 152:639, 1992.
  12. Paganini-Hill A, Hsu G, Ross RK, Henderson BE. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 326:1290, 1992. PMID: 1560810
  13. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breast feeding (letter). Lancet 361: 177, 2003.
  14. Heeb MJ, Fisher M, Paganini-Hill A. Association of low protein Z levels with ischemic stroke in young women. Thromb Haemost 97:495-496, 2007. PMID: 17334520
  15. Fisher M, Moores L, Paganini-Hill A. Factors affecting the preventability of stroke-reply. JAMA Neurol. 73:890-891, 2016.
  16. Fisher M, Paganini-Hill A. Infection and Stroke Risk. (Correspondence COVID-19 Cases). N Engl J Med, Apr 29, 2020.
  17. Fisher MJ, Paganini-Hill A, Kawas CH, Corrada MM, Fletcher E. White matter hyperintensities mediate the association of nocturnal blood pressure with cognition. Neurology 94(21), May 26, 2020.
  18. Fisher MJ, Paganini-Hill A, Kawas CH, Corrada MM, Fletcher E. Reader Response: White Matter Hyperintensities Mediate the Association of Nocturnal Blood Pressure With Cognition. Neurology. 2021 Jul 6;97(1):44-45. doi: 10.1212/WNL.0000000000012214. PubMed PMID: 34226284.

Editorials/Commentaries

  1. Paganini-Hill A. Aspirin and colorectal cancer: seems to reduce risk. Br Med J 307:278-279, 1993. PMID: 8374370 Full text
  2. Paganini-Hill A. Stroke and estrogen – opposed, unopposed or not at all? Menopause Digest 15(2):5-7, 2003.
  3. Corrada MM. Paganini-Hill A. Being overweight in adults aged 70-75 is associated with a reduction in mortality risk compared with normal BMI. Evidence-Based Medicine 15:126-127, 2010. PMID: 20530605

Invited Reviews

  1. Ross RK, Paganini-Hill A, Mack TM, Henderson BE. Cardiovascular benefits of estrogen replacement therapy. Am J Obstet Gynecol 160:1301-1306, 1989. PMID: 2655453 Full text
  2. Paganini-Hill A. The role of aspirin in the prevention of colon cancer. Cancer Prevention pp 1-8, April 1993.
  3. Paganini-Hill A. Does aspirin prevent cancer of the large bowel? J Irish Colleges Physicians Surgeons 23:183-188, 1994.
  4. Paganini-Hill A. Aspirin and the prevention of colorectal cancer: a review of the evidence. Seminars in Surgical Oncology 10:158-164, 1994. PMID: 8085092
  5. Paganini-Hill A. Estrogen replacement therapy and stroke. Prog Cardiovascular Dis 38:223-242, 1995. PMID: 7494884
  6. Paganini-Hill A. Long-term risks and benefits of estrogen replacement therapy. What a woman needs to know. Advance for Physician Assistants 4:18-21, 48; 1996.
  7. Paganini-Hill A. Estrogen replacement in the elderly. Zentralblatt für Gynäkologie 118:255-261, 1996. PMID: 8701621
  8. Henderson VW, Paganini-Hill A. Estrogen and Alzheimer’s disease. J SOGC Suppl:21-28, 1997.
  9. Paganini-Hill A, Henderson VW. Estrogen in the treatment and prevention of Alzheimer’s disease. Intl J Pharmaceutical Compounding 2(1):24-29, 1998.
  10. Paganini-Hill A. Alzheimer’s disease in women. Can estrogen play a preventive role? The Female Patient 23(3):10-20, 1998.
  11. Henderson VW, Benton D, Paganini-Hill A. Alzheimer’s disease and other dementing illnesses. The Female Patient 23(10):27-34, 1998.
  12. Paganini-Hill A, Henderson VW. Alzheimer’s disease: a role for estrogen replacement therapy? Orgyn (9)1:11-15, 1998.
  13. Paganini-Hill A. Alzheimer’s disease and estrogen replacement therapy. Postgraduate Obstet Gynecol 18(24):1-6, 1998. (Continuing Education course)
  14. Paganini-Hill A. Estrogen replacement therapy–something to smile about. The Compendium Suppl 22:S4-S8, 1998. (Continuing Education course) PMID: 12089760
  15. Paganini-Hill A. Alzheimer’s disease, women, and estrogen replacement therapy. Contemporary Ob/Gyn 44(5):110-125, 1999.
  16. Paganini-Hill A. Alzheimer’s disease in women: can estrogen play a preventive role? Menopause Review 4(2):68-76, 1999.
  17. Paganini-Hill A. Hormone replacement therapy and stroke: risk, protection, or no effect? Maturitas 38:243-261, 2001. PMID: 11358642
  18. Paganini-Hill A. Hormone replacement therapy and stroke: risk, protection, or no effect? Maturitas 42 Suppl 1:S11-S29, 2002.
  19. Paganini-Hill A. Hormone therapy and oral health. Menopause Management 16(3):31,32-40, 2007.

Chapters

  1. Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of prostate cancer. In Urological Cancer. DG Skinner (ed). New York: Grune and Stratton, Inc. pp 1-19, 1983.
  2. Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In Urological Cancer. DG Skinner (ed). New York: Grune and Stratton, Inc. pp 113-136, 1983.
  3. Paganini-Hill A, Ross RK, Henderson BE. Epidemiology of kidney cancer. In Urological Cancer. DG Skinner (ed). New York: Grune and Stratton, Inc. pp 383-407, 1983.
  4. Ross RK, Paganini-Hill A, Mack TM, Henderson BE. Estrogen use and cardiovascular disease. In The Menopause: Physiology and Pharmacology. DR Mishell Jr (ed). Chicago: Year Book Medical Publishers, Inc. pp 209-223, 1987.
  5. Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of bladder cancer. In Diagnosis and Management of Genitourinary Cancer. DG Skinner and G Lieskovsky (eds.). Philadelphia: WB Saunders Company, pp 23-31, 1988.
  6. Paganini-Hill A, Ross RK, Henderson BE. Epidemiology of renal cancer. In Diagnosis and Management of Genitourinary Cancer. DG Skinner and G Lieskovsky (eds.). Philadelphia: WB Saunders Company, pp 32-39, 1988.
  7. Ross RK, Paganini-Hill A, Henderson BE. Epidemiology of prostatic cancer. In Diagnosis and Management of Genitourinary Cancer. DG Skinner and G Lieskovsky (eds.). Philadelphia: WB Saunders Company, pp 40-45, 1988.
  8. Henderson BE, Ross RK, Shibata A, Paganini-Hill A, Yu MC. Environmental carcinogens and anticarcinogens. In Cancer Chemoprevention. L Wattenberg, M Lipkin, CW Boone, GJ Kelloff (eds.). Ann Arbor: CRC Press, pp 3-17, 1992.
  9. Paganini-Hill A. Morbidity and morality changes with estrogen replacement therapy. In Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. RA Lobo (ed). New York: Raven Press, pp 399-404, 1994.
  10. Henderson VW, Paganini-Hill A. Estrogens and Alzheimer’s disease. In Progress in Reproductive Medicine. R Asch, J Studd (eds). NY: Parthenon Publishing Group, Vol 2, pp 185-193, 1995.
  11. Paganini-Hill A. Morbidity and morality changes with estrogen replacement therapy. In Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. (2nd edition) RA Lobo (ed). New York: Lippincott Williams & Wilkins, pp 549-555, 1999.
  12. Perez Barreto M, Paganini-Hill A. Stroke, postmenopausal women and estrogen. In Management of the Menopause in the Millennium. JWW Studd (ed). London: Parthenon Publishing, pp 165-179, 1999.
  13. Paganini-Hill A. Morbidity and mortality changes with hormone therapy. In Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. (3rd edition) RA Lobo (ed). San Diego: Elsevier, pp 627-638, 2007.
  14. Kawas CH, Corrada MM, Paganini-Hill A. Estrogen therapy – Relationship to longevity and prevalent dementia in the oldest-old: The Leisure World Cohort Study and The 90+ Study. In Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies. E Hogervorst, VW Henderson, RB Gibbs, RD Brinton (eds). Cambridge University Press, pp 25-31, 2009.

Invited Papers (including those presented at Scientific Meetings)

  1. Ross RK, Mack TM, Hill A, Gerkins V, Menck H. Breast cancer and postmenopausal estrogen therapy in two Los Angeles retirement communities. In Long-term Studies on Side-effects of Contraception – State and Planning. U Kellhammer and K Űberla (ed). New York: Springer-Verlag. pp 59-73, 1978.
  2. Ross RK, Mack TM, Gerkins V, Paganini-Hill A. Breast cancer and menopausal estrogens. In Estrogens and Cancer. S Silverberg and Major (eds). New York: John Wiley and Sons, Inc. pp 55-64, 1978.
  3. Ross RK and Paganini-Hill A. Estrogen replacement and coronary heart disease. Sem Reprod Endocrinol 1:19-25, 1983.
  4. Ross RK, Paganini-Hill A, Henderson BE. The etiology of prostate cancer: what does the epidemiology suggest? The Prostate 4:333-344, 1983. PMID: 6688129
  5. Ross RK, Paganini-Hill A, Mack TM. Reduction in fractures and other effects of estrogen replacement in human populations. International Symposium on Osteoporosis, Copenhagen, Denmark, pp 289-297, 1984.
  6. Levine AM, Pavlova Z, Parker JW, Paganini-Hill A, Powars DR, Lukes RJ, Feinstein DI. B-cell small noncleaved undifferentiated lymphomas in adults. In New Perspectives in Human Lymphomas. RJ Ford, LM Fuller, FB Hagemeister (eds). New York: Raven Press, pp 321-326, 1984.
  7. Ross RK, Dworsky RL, Paganini-Hill A, Nichols P. The epidemiology of lymphomas. In Lymphoproliferative Diseases: Pathogenesis, Diagnosis, Therapy. PK Pattengale, RJ Lukes, CR Taylor (eds). Boston: Martinus Nijhoff Publishers. pp 55-71, 1985.
  8. Paganini-Hill A, Ross RK, Gray GE, Henderson BE. Vitamin A and cancer incidence in a retirement community. In Fourth Symposium on Epidemiology and Cancer Registries in the Pacific Basin. Natl Cancer Inst Monogr 69:133-135, 1985. PMID: 3834322
  9. Henderson BE, Ross RK, Paganini-Hill A. Estrogen use and cardiovascular disease. J Reprod Med 30 Suppl:814-820, 1985. PMID: 4078814
  10. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol 154:1181-1186, 1986. PMID: 3717228
  11. Henderson BE, Paganini-Hill A, Ross RK, Mack TM. Effects of estrogen on cardiovascular disease. Postgraduate Medicine 31-37, 1987.
  12. Paganini-Hill A. Estrogen replacement therapy and vascular disease: the Leisure World study. Postgraduate Medicine 49-50, 1989. PMID: 2726625
  13. Dworsky R, Paganini-Hill A, Spicer D. Breast cancer screening and education in high risk women. In Advances in Cancer Control: Innovations and Research. Prog Clin Biol Res 293:115-124, 1989. PMID: 2726926
  14. Ross RK, Bernstein L, Paganini-Hill A, Henderson BE. Effects of smoking on ‘hormone-related’ diseases in a Southern California retirement community. In Smoking and Hormone-Related Disorders. N Wald, J Baron (eds.) Oxford: Oxford University Press, pp 32-54, 1990.
  15. Spicer D, Pike M, Lobo R, Paganini-Hill A, Richardson J, Dworsky R, Weaver F. Gonadotropin hormone releasing hormone agonists (GnRHA) and prevention of familial breast cancer. Advances in Cancer Control: Screening and Prevention Research. Prog Clin Biol Res 339:193-199, 1990. PMID: 2168048
  16. Henderson BE, Paganini-Hill A, Ross RK. The effect of estrogen replacement therapy on mortality. Primary Cardiology 18:56-64, 1992.
  17. Paganini-Hill A. The risks and benefits of estrogen replacement therapy: Leisure World. Int J Fertil 40 Suppl 1:54-62, 1995. PMID: 7581589
  18. Paganini-Hill A. Aspirin and colorectal cancer: the Leisure World Cohort revisited. Preventive Medicine 24:113-115, 1995. PMID: 75997009
  19. Paganini-Hill A. Oestrogen replacement and Alzheimer’s disease. Br J Obstet Gynecol 103 (Suppl 13):80-86, 1996. PMID: 8624348
  20. Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. A pilot study of urinary estrogen metabolites (16α-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer. Environ Health Perspect 105 (Suppl 3):601-605, 1997. PMID: 9168002 Full text
  21. Paganini-Hill A. Does estrogen replacement therapy protect against Alzheimer’s disease? Osteoporosis International Suppl 1:S12-S17, 1997. PMID: 9205640
  22. Paganini-Hill A. Hormones and dementia in elderly women. Revolutionizing Women’s Health: A Consensus Conference. Golden, CO: Medical Education Collaborative. pp 14-17, 1998.

Other Invited Scientific Presentations

  1. Paganini-Hill A. Measurement of dietary vitamin A using a food frequency questionnaire. Joint Symposium sponsored by Fred Hutchinson Cancer Research Center, University of Washington School of Medicine and Department of Preventive Medicine, USC School of Medicine. Seattle, Washington, October 1987.
  2. Paganini-Hill A. Estrogen replacement therapy and protection from acute myocardial infarction and stroke mortality. Second Annual Symposium on the Long-term Effects of Estrogen Deprivation. St. John, US Virgin Islands, February 1988.
  3. Dworsky RL, Paganini-Hill A, Spicer D. Breast Cancer Screening and Education in High Risk Women. Third Annual Meeting of the National Consortium of Breast Centers. Los Angeles, California, March 1988.
  4. Paganini-Hill A. Estrogen replacement therapy reduces the risk of Alzheimer’s disease. Seventh Annual Symposium on the Long-term Effects of Estrogen Deprivation. Victoria, British Columbia, Canada, July 24-27, 1993.
  5. Paganini-Hill A. Estrogen replacement therapy and Alzheimer’s Disease. Visiting Professor Program, Wyeth-Ayerst Laboratories. Philadelphia, PA, October 8, 1993.
  6. Paganini-Hill A. The long-term effects of estrogen deprivation as revealed in the Leisure World Cohort. Visiting Faculty Conference: Flexibility in the Management of Postmenopausal Women, Bristol-Myers Squibb Company. Dallas, TX, April 8-9, 1994.
  7. Paganini-Hill A. Risk and benefit of ERT. Symposium on Women’s Health after Menopause: Lifestyle Factors and Health Issues of Menopause, 7th Meeting of the Belgian Menopause Society. Brussels, Belgium, October 22, 1994.
  8. Paganini-Hill A. Estrogen replacement therapy and Alzheimer’s disease. Roundtable Symposium on Dose and Formulation of Estrogen Therapy for the Prevention and Treatment of Postmenopausal Disease. Chicago, IL, April 8, 1995.
  9. Paganini-Hill A. Estrogen: From tooth loss to Alzheimer’s disease. Twenty-third Annual Physician Assistant Conference. Las Vegas, NV, June 1, 1995.
  10. Paganini-Hill A. HRT and Alzheimer’s disease: What does the epidemiologic evidence suggest? Sixth Annual Meeting of the North American Menopause Society. San Francisco, CA, September 21-23, 1995.
  11. Paganini-Hill A. Personalizing cohort studies: Part I. Women’s Health Update Goes on the Road. Los Angeles, CA, May 16, 1996.
  12. Paganini-Hill A. Alzheimer’s and HRT: What is the research telling us? Advances in Health Care for Women Over 40. Los Angeles, CA, May 16, 1996.
  13. Paganini-Hill A. ERT and Alzheimer’s disease. Innothera Workshop. HRT Tomorrow: Other Concerns. Paris, France, September 20, 1996.
  14. Paganini-Hill A. Sex steroids and central nervous system. Health Council on Osteoporosis International Symposium. Estrogens and Estrogen Like Substances in Women’s Health: the Year 2000. Paris, France, October 25, 1996.
  15. Paganini-Hill A. Hormones and dementia in elderly women. Revolutionizing Women’s Healthcare: A Consensus Conference. Cancun, Mexico, January 15-18, 1998.
  16. Paganini-Hill A. Estrogen replacement therapy and colorectal cancer in elderly women. Twelfth Annual Symposium on the Long-term Effects of Estrogen Deprivation. Los Capos, Mexico. July 13-15, 1998.
  17. Paganini-Hill A. Tamoxifen: CNS effects. Twelfth Annual Symposium on the Long-term Effects of Estrogen Deprivation. Los Capos, Mexico. July 13-15, 1998.
  18. Paganini-Hill A. Prevention and/or treatment of Alzheimer’s disease: What role should HRT play? USC School of Medicine Postgraduate Division Continuing Medical Education Program: Hormone Replacement Therapy — Evaluation of Benefits and Risks. Newport Beach, CA. October 10, 1998.